Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline

YP Chen, N Ismaila, MLK Chua, AD Colevas… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to
practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy …

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

P Bossi, AT Chan, L Licitra, A Trama… - Annals of …, 2021 - annalsofoncology.org
Nasopharyngeal carcinoma (NPC) is a disease with unique epidemiological features. The
distribution of the disease demonstrates a clear regional, racial and gender prevalence. In …

[HTML][HTML] Systematic review and meta-analysis of the association between radiation therapy treatment volume and patient outcomes

JYA Kyaw, A Rendall, EF Gillespie, T Roques… - International Journal of …, 2023 - Elsevier
Purpose Evidence of a volume–outcome association in cancer surgery has shaped the
centralization of cancer services; however, it is unknown whether a similar association exists …

[HTML][HTML] Nasopharyngeal carcinoma. A “different” head and neck tumour. Part B: treatment, prognostic factors, and outcomes

G Cantù - Acta Otorhinolaryngologica Italica, 2023 - ncbi.nlm.nih.gov
Nasopharyngeal carcinoma (NPC) is the most interesting and intriguing malignant tumour
located in the nasopharynx, because it is a “peculiar” malignancy,“different” from almost all …

CircRNA ZNF609 knockdown suppresses cell growth via modulating miR-188/ELF2 axis in nasopharyngeal carcinoma

M Li, Y Li, M Yu - OncoTargets and therapy, 2020 - Taylor & Francis
Background Circular RNAs (circRNAs) and microRNAs (miRNAs) have been reported to act
as the important regulators in nasopharyngeal carcinoma (NPC). CircRNA ZNF609 (circ …

The impact of facility type and volume on treatment and overall survival in craniopharyngioma

BF Bitner, DH Liu, MM Nottoli, SJ Torabi, FPK Hsu… - Pituitary, 2023 - Springer
Background Craniopharyngiomas are uncommon benign sellar and parasellar tumors with
high overall survival (OS) and recurrence rates. Treatment is often surgical but may include …

Sinonasal squamous cell carcinoma outcomes: does treatment at a high-volume center confer survival benefit?

JI Teitelbaum, K Issa, IR Barak… - … –Head and Neck …, 2020 - journals.sagepub.com
Objective To determine whether treatment of sinonasal squamous cell carcinoma (SCC) at a
high-volume facility affects survival. Study Design Retrospective database analysis. Setting …

The influence of facility volume and type on skull base chordoma treatment and outcomes

AT Du, JC Pang, R Victor, LLT Meller, SJ Torabi… - World Neurosurgery, 2022 - Elsevier
Objective To evaluate the influence of facility case volume and type on skull base chordoma
treatment and overall survival (OS). Methods The 2004–2016 National Cancer Database …

Academic affiliation and surgical volume predict survival in head and neck cancer patients receiving surgery

DR Farquhar, MM Masood, NR Lenze… - The …, 2021 - Wiley Online Library
Objective To determine whether the academic affiliation or surgical volume affects the
overall survival (OS) of human papillomavirus (HPV)–negative head and neck squamous …

Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma

NCJ Lee, JR Kelly, Y An, HS Park, BL Judson… - Cancer, 2019 - Wiley Online Library
Background Treatment at high‐volume surgical facilities (HVSFs) provides a survival benefit
for patients with head and neck squamous cell carcinomas (HNSCCs); however, it is …